Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Lipocine Inc (Lipocine) is a biopharmaceutical company that develops products for neurological and psychiatric central nervous system (CNS) disorders, liver diseases, and hormone supplementation for men and women. It uses lipral platform to develop products through the oral delivery. The company’s pipeline products include LPCN 1144 which treats non-alcoholic steatohepatitis (NASH); TLANDO to restore normal testosterone levels in males; LPCN 1111 is an oral testosterone product; LPCN 1148 for cirrhosis; LPCN 1107 treats for the prevention of recurrent preterm birth; LPCN 1154 which treats postpartum depression. It collaborates with pharmaceutical companies. Lipocine is headquartered in Salt Lake City, Utah, the US.
Headquarters
United States of America
Address
675 S Arapeen Dr Ste 202, Salt Lake, Utah, 84108-1295
Website
www.lipocine.com
Telephone
1 801 9947383
No of Employees
14
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
LPCN (NASD)
Revenue (2025)
$2.0M
-82.3%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
-115399.5%
(2025 vs 2024)
Market Cap*
$20.3M
Net Profit Margin (2025)
XYZ
-695,885.7%
(2025 vs 2024)
* As of and is in US$
Lipocine Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| LPCN 1144 -Non-Alcoholic Steatohepatitis (NASH) | TLANDO |
| TLANDO - Restore Normal Testosterone Levels in Males | |
| LPCN 1111 - Oral Testosterone Product | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Lipocine Inc | Cumberland Pharmaceuticals Inc | Acumen Pharmaceuticals Inc | ContraFect Corp | Dicerna Pharmaceuticals Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Salt Lake | Nashville | Newton | Yonkers | Lexington |
| State/Province | Utah | Tennessee | Massachusetts | New York | Massachusetts |
| No. of Employees | 14 | 93 | 61 | 23 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Spyros Papapetropoulos, MD, Ph.D | Chairman | Executive Board | 2022 | 52 |
| Mahesh V. Patel, Ph.D | Chief Executive Officer; Director; President | Executive Board | 1997 | 68 |
| KRISTA FOGARTY | Principal Accounting Officer; Controller - Corporate | Senior Management | 2022 | 58 |
| Chidu Chidambaram, PH.D | Vice President - Product Development | Senior Management | - | - |
| Nachiappan Chidambaram, Ph.D. | Senior Vice President - Research and Development | Senior Management | 2022 | 56 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer